EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Effect of GLP1 Agonists on Reproduction

Marie Couldwell iD, Anna Jane Tidwell iD, Ann E Taylor iD

The Journal of Clinical Endocrinology & Metabolism · 16.10.2025 · 110 (11) · 3009-3024

DOI: 10.1210/clinem/dgaf401 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 14.07.2025. Verfasst von Marie Couldwell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Spencer Fox Eccles School of Medicine, Division of Endocrinology, University of Utah, Salt Lake City, UT 84113, USA. Hauptthemen laut MEDLINE: Reproduction, Glucagon-Like Peptide 1, Obesity. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 137 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity, in animals and humans, is associated with male and female reproductive dysfunction. Elucidating the mechanisms by which excessive weight affects reproduction and proving that weight loss improves reproductive function has been difficult. Data in animals and humans demonstrate improvements in reproductive function after weight loss, achieved with or without glucagon-like peptide 1 (GLP1) agonists. In preclinical studies there is evidence that GLP1 agonists have direct effects on the hypothalamus to stimulate luteinizing hormone (LH) secretion and direct beneficial effects on the gonads and the endometrium. Whether GLP-1 agonists provide an added direct beneficial effect on reproductive organs in humans, beyond the benefits mediated by weight loss, remains unclear. However, consideration of GLP1 agonists for the treatment for obesity-associated reproductive dysfunction requires caution, as any weight loss during pregnancy is associated with adverse fetal outcomes, and preclinical studies indicate fetal toxicity of the GLP1 agonist class. Here, we review the available preclinical and clinical evidence of the effects of GLP-1 agonists on human reproductive health, suggest a therapeutic strategy, and list the needs for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ReproductionGlucagon-Like Peptide 1ObesityHumansFemaleAnimalsPregnancyMaleGlucagon-Like Peptide-1 Receptor Agonists

Stichwörter der Autor:innen

GLP1femalefertilityhumanmalereproductionweight loss

Substanzen

Glucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Spencer Fox Eccles School of Medicine, Division of Endocrinology, University of Utah, Salt Lake City, UT 84113, USA.
  • Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT 84113, USA.
  • North Kingstown, RI 02852, USA.

ORCID-Profile: Marie Couldwell, Anna Jane Tidwell, Ann E Taylor

Zitieren

APA

Couldwell, M., Tidwell, A. J., & Taylor, A. E. (2025). Effect of GLP1 Agonists on Reproduction. The Journal of Clinical Endocrinology & Metabolism, 110(11), 3009-3024. https://doi.org/10.1210/clinem/dgaf401

Vancouver

Couldwell M, Tidwell AJ, Taylor AE. Effect of GLP1 Agonists on Reproduction. The Journal of Clinical Endocrinology & Metabolism. 2025;110(11):3009-3024. doi:10.1210/clinem/dgaf401

BibTeX
@article{Couldwell2025,
  author = {Couldwell, Marie and Tidwell, Anna Jane and Taylor, Ann E},
  title = {Effect of GLP1 Agonists on Reproduction},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {11},
  pages = {3009--3024},
  doi = {10.1210/clinem/dgaf401}
}
Kostenlos starten →